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Asymptomatic Bile Duct Dilatation in Children: Is It a Disease?
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Purpose: Bile duct dilatation is a relatively common sonographic finding; nevertheless, its clinical significance in 
children is controversial because little research has been done in the area. Therefore, we investigated the natural 
course and clinical significance of biliary duct dilatation in children.
Methods: We performed a retrospective study of 181 children (range, 1-day-old to 17-year-old) in whom dilatation 
of the intrahepatic duct and/or common hepatic duct and/or common bile duct was detected by abdominal ultra-
sonography at the Severance Children's Hospital between November 2005 and March 2014. We reviewed and ana-
lyzed laboratory test results, clinical manifestations, and clinical course in these patients.
Results: Pediatric patients (n=181) were enrolled in the study and divided into two groups. The first group included 
59 subjects, without definitive cause of bile duct dilatation, who did not require treatment; the second group included 
122 subjects, with definitive cause of bile duct dilatation or underlying biliary disease, who did require treatment. 
In the first group, 24 patients (40.7%) showed spontaneous resolution of bile duct dilatation, 20 patients (33.9%) 
showed no change, and 15 patients (25.4%) were lost to follow-up. In the second group, 31 patients were diagnosed 
with choledochal cysts, and 91 patients presented with biliary tract dilatations due to secondary causes, such as 
gallbladder or liver disease, post-operative complications, or malignancy.
Conclusion: Biliary dilatation in pediatric patients without symptoms, and without laboratory and other sonographic 
abnormalities, showed a benign clinical course. No pathologic conditions were noted on follow-up ultrasonography.
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INTRODUCTION
By convention, the upper normal limit for the di-
ameter of the common bile duct, measured by ultra-
sound, is 7 mm [1-4]. Although these criteria are 
generally accepted, what is considered normal bile 
duct diameter is somewhat controversial because of 
the vagueness of the age criteria and various con-
ditions, such as previous cholecystectomy, drug 
treatment, and the imaging modality itself that can 
affect the diameter measurement [5]. The ease and 
convenience of ultrasonography have led to its in-
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Fig. 1. Patient flow chart.
creased use for abdominal examination; the in-
creased use of abdominal ultrasound has led to more 
frequent observation of biliary dilatation. Although 
bile duct dilatation has become a common sono-
graphic finding, the clinical significance of asympto-
matic bile duct dilatation has been controversial; 
there has been little research in this area to provide 
sound guidelines. In adults, asymptomatic biliary di-
latation should be carefully evaluated because of the 
possibility of malignancy [6]. However, the causes of 
bile duct dilatations in the pediatric population differ 
from those of adults, with a lower prevalence of ma-
lignancy and higher prevalence of congenital ano-
malies [7]. Ultrasonography is a very sensitive and 
specific technique for diagnosing biliary diseases, as 
demonstrated in several studies [8,9]. We hypothe-
size that patients with localized biliary dilatation 
have a higher probability for a benign clinical course 
and prognosis. The aim of this study was to identify 
the natural course and clinical significance of in-
cidentally discovered biliary tract dilatations in pe-
diatric patients with normal liver enzymes, by ana-
lyzing resolution rates, final diagnoses, sites of bile 
duct dilatations, patients’ characteristics, and labo-
ratory tests.
MATERIALS AND METHODS
We retrospectively evaluated 181 patients aged 
0-17 years with biliary tract dilatation (intrahepatic 
duct, common hepatic duct, and common bile duct 
dilatation) as shown by sonography performed be-
tween November 2005 and March 2014 at the 
Severance Children’s Hospital (Seoul, Korea). 
Ultrasound was performed for a variety of signs and 
symptoms, such as vomiting, abdominal pain, ab-
dominal mass, jaundice, and fever of unknown 
origin. Patients with established choledochal cysts 
who were referred from other hospitals were 
excluded. Patient age, site of the biliary tract dilata-
tion, laboratory test results, ultrasound findings, fol-
low-up duration, and dilatation resolution were 
analyzed. We divided patients with biliary tract dila-
tation into two groups: one group consisted of pa-
tients with primary ductal dilatation with normal 
laboratory and sonographic findings; the second 
group included patients with ductal dilatation sec-
ondary to other diseases. We used the following di-
agnostic criteria for this study: normal common bile 
duct diameter, measured by abdominal ultra-
sonography of neonates was ＜1 mm, infants 
＜2-3.5 mm, older children ＜4 mm, adolescents, 
and adults ＜7 mm. Normal internal diameter of the 
common hepatic duct, measured by abdominal ul-
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Table 1. Diagnosis of All Patients with Biliary Dilatation by 
Abdominal Ultrasonography
Ultrasonographic finding Patient number (%)
Primary ductal dilatation
Secondary ductal dilatation
  Choledochal cyst, anomalous 
   pancreaticobiliary ductal union
  Gall bladder disease*
  Liver disease
  Post operation status†
  Cholestasis
  Others‡
Total
        59 (32.6)
       122 (67.4)
        31 (17.1)
        30 (16.6)
        18 (9.9)
        25 (13.8)
         4 (2.2)
        14 (7.7)
       181 (100)
*Gallbladder stone, sludge, hydrops. †Liver transplantation, Kasai
operation, choledochal cyst excision. ‡Pancreatitis, trauma, ma-
lignancy, hemangioma.
Fig. 2. Distribution of study 
population, presumed cause 
of bile duct dilatation, and 
outcome of primary ductal 
dilatation on follow-up. Of 
181 patients with ductal dila-
tations, 59 (32.6%) had 
primary ductal dilatations.
trasonography of infants was ＜2 mm, older children 
＜3 mm, and children aged 12 to 16 years ＜4 mm 
[1,2]. Two experienced pediatric radiologists per-
formed ultrasonography. We defined the resolution 
group as those who showed spontaneous resolution 
to normal bile duct diameter in follow-up ultra-
sounds, and the non-resolution group as those with 
persistent bile duct dilatation. We used K-test, 
Mann-Whitney test, and chi-square test for compar-
isons between groups. The Statistical Package for the 
Social Sciences (PASW Statistics ver. 18.0; IBM Co., 
Armonk, NY, USA) was used for all analyses.
RESULTS
Of 11,859 abdominal ultrasonography procedures 
that were carried out during the period, 181 cases 
satisfied the inclusion criterion of dilated duct(s); 
11,678 cases did not fulfill the inclusion criterion and 
were excluded (Fig. 1). Twenty-five patients (13.8%) 
had a hepatobiliary surgical history, where the dila-
tations appeared to result from post-operative 
complications. Thirty-one patients (17.1%) had con-
genital anomalies, such as a choledochal cyst or 
anomalous pancreaticobiliary ductal union. Thirty 
patients (16.6%) had gallbladder disease, and 18 pa-
tients (9.9%) had liver disease (1 hepatitis B virus in-
fection, 1 fibropolycystic liver disease, 16 nonspecific 
reactive hepatitis). Fourteen patients (7.7%) were 
diagnosed with pancreatitis, trauma, malignancy, or 
hemangioma. Four patients (2.2%) had cholestasis 
with jaundice (3 total parenteral nutrition induced 
cholestasis, 1 drug induced cholestasis). Fifty-nine 
patients (32.6%) showed primary ductal dilatation 
without any apparent cause (Table 1). Among the 59 
patients with primary ductal dilatations, 44 patients 
(74.6%) underwent follow-up ultrasound scans, 
with a mean follow-up period of 28 months (range, 
1-95 months). Fifteen patients (25.4%) were lost to 
follow-up. Twenty-four cases of primary ductal dila-
tation (40.7%) resolved gradually (these patients 
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Table 2. Comparison of Demographic, Laboratory, and Sonographic Findings of Patients with Primary and Secondary Ductal 
Dilatations
Primary ductal dilatation 
(n=59)
Secondary ductal dilatation 
(n=122)
p-value
Age (mo)
Extrahepatic bile duct dilatation (mm)
Aspartate transaminase (IU/L)
Alanine transaminase (IU/L)
Alkaline phosphatase (IU/L)
Total bilirubin (mg/dL)
Direct bilirubin (mg/dL)
Amylase (U/L)
Lipase (U/L)
            24 (0-96)
            4.4 (3.0-6.0)
            26 (20-32)
            12 (9-17)
           162 (124-212)
            0.5 (0.2-2.7)
            0.4 (0.2-0.8)
            48 (45-85)
            17 (16-22)
            24 (3-72)
            5.0 (4.0-6.0)
            35 (25-105)
            30 (13-82)
           184 (135-296)
           0.65 (0.3-3.5)
            0.7 (0.1-1.9)
            57 (28-93)
            25 (19-67)
    0.958
    0.110
  ＜0.001
  ＜0.001
    0.062
    0.171
    0.180
    0.942
    0.059
Values are presented as median (interquartile range).
Table 3. Predictive Factors for Resolution of Primary Ductal Dilatation
Resolution (n=24) Non-resolution (n=20) p-value
Age (mo)
Extrahepatic bile duct dilatation (mm)
Aspartate transaminase (IU/L)
Alanine transaminase (IU/L)
Alkaline phosphatase (IU/L)
Total bilirubin (mg/dL)
Direct bilirubin (mg/dL)
Amylase (U/L)
Lipase (U/L)
           12.0 (2.7-72)
            5.0 (3.0-6.0)
            35 (26-88)
            28 (12-71)
           196 (135-298)
            0.8 (0.3-3.7)
            0.7 (0.2-2.3)
            46 (17-83)
            22 (17-40)
           24.0 (4.5-78)
            4.7 (3.0-6.0)
           32.5 (23-104)
            21 (10-146)
           158 (121-228)
           0.45 (0.2-3.3)
            0.8 (0.2-1.8)
            86 (35-339)
            19 (12-708)
    0.746
    0.173
    0.265
    0.276
    0.433
    0.903
    0.061
    0.120
    0.378
Values are presented as median (interquartile range).
Table 4. Comparison of the Resolution Rates of Primary Ductal
Dilatation Depending on Dilation Sites
Dilation site Dilated IHD Dilated EHD
Dilated 
IHD＋EHD
Resolution rate 1/6 (16.7%) 22/48 (45.8%) 1/5 (20.0%)
IHD: intrahepatic bile duct dilatation, EHD: extrahepatic bile 
duct dilatation (including common bile duct dilatation and 
common hepatic duct dilatation).
comprised the resolved group). In the remaining 20 
cases, dilatations (33.9%) did not resolve until the 
last evaluation (median follow-up duration: 1 year 3 
months; these patients comprised the non-resolved 
group) (Fig. 2). When we compared laboratory tests 
between the primary and secondary ductal dilatation 
groups, aspartate transaminase and alanine trans-
aminase were significantly higher in the secondary 
ductal dilatation group (p＜0.001; Table 2). However, 
this result might be biased due to the heterogeneity 
of the secondary ductal dilatation group. When we 
compared laboratory test results between the re-
solved group and the non-resolved group of the pri-
mary ductal dilatation patients, there were no sig-
nificant differences. No predictive factor associated 
with resolution was observed in the primary ductal 
dilatation patients. Furthermore, when we inves-
tigated whether there could be a factor that was pre-
dictive of resolution, none was identified that 
showed a difference between the resolved group and 
the non-resolved group of primary ductal dilatation 
patients (Table 3). Comparison of the resolution 
rates depending on dilatation site was also con-
ducted; patients with dilatations only in extra-
hepatic ducts showed the highest rate of resolution 
(45.8%) (Table 4). With respect to dilatation sites, we 
investigated the likelihood of being diagnosed with 
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Table 5. Diagnostic Difference according to Dilatation Sites
IHD EHD IHD+EHD Total
Primary ductal dilatation
Secondary ductal dilatation
 6 (10.2%)
29 (23.8%)
48 (81.4%)
56 (45.9%)
5 (8.5%)
37 (30.3%)
 59 (100%)
122 (100%)
IHD: intrahepatic bile duct dilatation, EHD: extrahepatic bile duct dilatation (including common bile duct dilatation and common
hepatic duct dilatation).
other diseases. We found that more patients with on-
ly extrahepatic duct dilatations belonged to the pri-
mary ductal dilatation group than the secondary 
ductal dilatation group (Table 5). All groups divided 
according to dilatation sites showed similar pro-
portions of secondary ductal dilatations, but patients 
with only extrahepatic duct dilatation had the high-
est percentage of primary ductal dilatations. This dif-
ference was statistically significant when analyzed 
by chi square test (p＜0.001).
DISCUSSION
Reported cases of dilatated biliary tracts (such as 
choledochal cyst or bile duct carcinoma) have a high-
er prevalence in Asia than Western countries [10]. 
Furthermore, the majority of patients who reported 
having choledochal cyst disease are children. In na-
tionwide survey of Korean children, acquired biliary 
diseases and congenital hepatobiliary diseases were 
7.6% and 12.6% of total hepatobiliary diseases re-
spectively [11]. Therefore, it is important to define 
abnormal bile duct dilatation because of its possible 
association with congenital malformation and pa-
thologic conditions, such as infection, calculi, biliary 
dysfunction, and malignancy [6,12-16]. 
Ultrasonography is a useful method to evaluate 
the biliary tract system in children. It is rapid, non-
invasive, and does not involve radiation exposure 
[17]. Although there have been several studies re-
garding bile duct measurement in children, no 
worldwide standards on range of normal size of bili-
ary ducts in different pediatric age groups have been 
accepted [12,18,19]. For this study, we applied 
Siegel’s diagnostic criteria [20], where common bile 
duct dilatation was defined as a diameter greater 
than 2 mm, 4 mm, and 7 mm in patients 1 month, 12 
years, and 16 years of age, respectively. Likewise, 
common hepatic duct dilatation was defined as a di-
ameter greater than 2 mm, 3 mm, and 4 mm in pa-
tients 1 month, 12 years, and 16 years of age, respec-
tively. 
Bile duct dilatation can result from a variety of 
causes. The most common etiology is bile duct ob-
struction, which may present as acute abdominal 
pain and/or jaundice, and is revealed by an abnormal 
liver function test [21-23]. In addition, there have 
been several reports on biliary duct dilatation as a 
post-operative change [24-26]. Lee et al. [27] dem-
onstrated that among 162 patients, 131 cases had 
anomalous biliary tract dilatations and 31 cases had 
non-anomalous biliary dilatations consisting of nor-
mal variants or resulting from secondary causes. 
Although we could not identify a standard diameter 
of the common bile duct that indicated the presence 
of possible causative lesions, we believe that a com-
mon bile duct diameter greater than 7 mm is an arbi-
trary standard that needs further evaluation, in or-
der not to overlook significant biliary tract lesions 
[28].
Occasionally, we have observed biliary duct dilata-
tion on abdominal sonography, which was not corre-
lated with the patient’s symptoms and laboratory 
test results. In adults, there have been only a few 
studies on the prognosis and outcome in asympto-
matic patients with biliary tract dilatation and nor-
mal liver enzyme test results [4,6,28]. However, 
there have been no reports regarding the causes of 
common bile duct dilatation in healthy pediatric 
populations, and no guidelines are available as to 
whether we should perform further study in those 
patients. Therefore, the aim of our study was to iden-
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tify the clinical significance of asymptomatic bile 
duct dilatation and long-term outcome in pediatric 
patients.
In our study, 181 patients were enrolled and of 
these, 59 patients (32.6%) had no causative lesion, 
remained asymptomatic, and kept a benign course 
upon follow-up study. In addition, patients with on-
ly extrahepatic duct dilatation had the highest pro-
portion (81.4%) of primary ductal dilatation and 
highest rate of resolution (45.8%). Our findings are 
inconsistent with previous adult studies. Jeon et al. 
[6] reported that patients with intrahepatic duct di-
latation accounted for the majority of patients with 
normal laboratory test results and no causative 
lesions.
We hypothesized that patients with localized bili-
ary dilatation have a higher probability for a benign 
course and prognosis, but that the outcome may de-
pend on dilatation site. In patients with localized 
biliary dilatation, the biliary duct dilatation can oc-
cur because of a temporary bile flow disturbance. 
Additional research is necessary to prove this 
hypothesis.
In our study, 74% of patients with primary ductal 
dilatation showed spontaneous resolution or re-
mained unchanged during the study interval. In 
these patients, no pathologic conditions emerged on 
ultrasonography during the follow-up period. 
Our study had several limitations. First was its ret-
rospective design: patients could not be investigated 
under the same conditions even in the absence of 
symptoms. Asymptomatic patients tended to be lost 
during follow-up according to patient’s or doctor’s 
preference, which might have contributed to bias in 
the information that was recorded. In addition, be-
cause sonography has become so easily accessible, 
the rate of incidentally found biliary dilatation has 
greatly increased. Because this study had a mean fol-
low-up period of 28 months, a longer follow-up peri-
od is necessary to obtain long-term outcomes. 
Furthermore, even though experienced radiologists 
reviewed the results, bias could have resulted from 
subjectivity of the radiologist and the limitations of 
ultrasound technology. Therefore, additional inves-
tigations are needed to evaluate long-term prognosis 
and outcome, and to compare clinically relevant 
findings in patients with similar findings by endo-
scopic retrograde cholangiopancreatography or ma-
gnetic resonance cholangiopancreatography. 
In conclusion, incidentally discovered biliary dila-
tation without any symptoms or abnormalities in 
laboratory and ultrasound tests in children could be 
defined as primary ductal dilatation and considered 
a non-pathologic condition. This condition was asso-
ciated with a relatively benign clinical course and did 
not require medical intervention.
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